Вісник проблем біології і медицини -2023 -Вип. 4 (171) / Bulletin of problems in biology and medicine -2023 -Issue 4 (171) 199
КЛІНІЧНА ТА ЕКСПЕРИМЕНТАЛЬНА МЕДИЦИНА / CLINICAL AND EXPERIMENTAL MEDICINE2) a subgroup of "Ideal Hypertension" (n=125), which included people with hypertension according to both ESC/ ESH (2018) and ACC/AHA (2017) criteria;3) a subgroup of "Intermediate BP" (n=254), which included people with hypertension according to ACC/AHA criteria (2017) and "high norm" according to ESC/ESH criteria (2018).To determine the CVR, the following methods were used: PROCAM risk score; Framigham risk score based on lipid profile; Framigham risk score based on body mass index; QRISK 2 risk score; Pooled Cohort Equations risk score; ASCVD risk score.Results. The average values of the CVR level in the "Ideal Normotension" subgroup of the DM2 group were 8.5% (95% CI. 7.80; 9.28). In the "Intermediate BP" subgroup, this indicator corresponded to 12.9% (95% CI.12.32; 13.51), and in the subgroup of "Ideal hypertension" the value of cardiovascular risk was 18.0% (95% CI 17.43; 18.55). The differences between all subgroups were statistically highly significant: p <0.001.Conclusions. The use of CVR calculators both individually and in combination in patients in the DM2 group indicate that an increase in SBP to 130-139 mmHg and/or DBP to 80-89 mmHg contributed to an increase in cardiovascular risk. It can be assumed that a further increase in blood pressure further increases this risk.